Metfor - V 50mg:500mg Tablet Price in Pakistan

View latest Price, manufacturer, formulation, and pack details of Metfor - V 50mg:500mg Tablet.

Available Products of Metfor - V 50mg:500mg Tablet

Metfor - V 50mg:500mg Tablet 14's

Reg#: 113000

Description of Metfor - V 50mg:500mg Tablet

Vildagliptin……50mgMetformin HCl…….500mg

Medicine Info

Pack Size: 14's

Company: Valor Pharmaceuticals

Price of Metfor - V 50mg:500mg Tablet

Price: Rs. 892.80

Related Keywords

  • Metfor - V 50mg:500mg Tablet price in Pakistan
  • Metfor - V 50mg:500mg Tablet tablet price
  • Metfor - V 50mg:500mg Tablet Capsule price
  • Valor Pharmaceuticals Metfor - V 50mg:500mg Tablet price
  • Buy Metfor - V 50mg:500mg Tablet online
  • Metfor - V 50mg:500mg Tablet vildagliptin50mgmetformin uses
  • Metfor - V 50mg:500mg Tablet syrup price
  • Metfor - V 50mg:500mg Tablet pack 14's cost

Metfor - V 50mg:500mg Tablet 28's

Reg#: 113000

Description of Metfor - V 50mg:500mg Tablet

Vildagliptin……50mgMetformin HCl…….500mg

Medicine Info

Pack Size: 28's

Company: Valor Pharmaceuticals

Price of Metfor - V 50mg:500mg Tablet

Price: Rs. 1785.60

Related Keywords

  • Metfor - V 50mg:500mg Tablet price in Pakistan
  • Metfor - V 50mg:500mg Tablet tablet price
  • Metfor - V 50mg:500mg Tablet Capsule price
  • Valor Pharmaceuticals Metfor - V 50mg:500mg Tablet price
  • Buy Metfor - V 50mg:500mg Tablet online
  • Metfor - V 50mg:500mg Tablet vildagliptin50mgmetformin uses
  • Metfor - V 50mg:500mg Tablet syrup price
  • Metfor - V 50mg:500mg Tablet pack 28's cost

Alternatives brands of Metfor - V 50mg:500mg Tablet

Explore alternative brands for Metfor - V 50mg:500mg Tablet below.

View Alternatives

Explore More Medicines

Valofibren 67mg Capsules

Valor Pharmaceuticals

MRP: Rs. 97.2000

Valofibren 67mg Capsules

Valor Pharmaceuticals

MRP: Rs. 145.2000

Valofon Cream 1%

Valor Pharmaceuticals

MRP: Rs. 120.0000

Valobrinz Eye Drops 1% w:w

Valor Pharmaceuticals

MRP: Rs. 597.6000

Mycona-GB Cream

Valor Pharmaceuticals

MRP: Rs. 124.4400

We’d love to hear your thoughts!

Share your comment below and join the conversation ✨

Comments

No comments yet. Be the first!